Boston Common Asset Management LLC Has $7.81 Million Stake in Danaher Co. (DHR)

Boston Common Asset Management LLC lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 5.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 71,828 shares of the conglomerate’s stock after selling 4,405 shares during the quarter. Danaher makes up 1.0% of Boston Common Asset Management LLC’s portfolio, making the stock its 28th largest holding. Boston Common Asset Management LLC’s holdings in Danaher were worth $7,805,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the company. Synovus Financial Corp lifted its stake in shares of Danaher by 21.2% during the 3rd quarter. Synovus Financial Corp now owns 122,911 shares of the conglomerate’s stock valued at $13,353,000 after buying an additional 21,495 shares in the last quarter. Klingenstein Fields & Co. LLC lifted its stake in shares of Danaher by 924.8% during the 3rd quarter. Klingenstein Fields & Co. LLC now owns 40,151 shares of the conglomerate’s stock valued at $4,363,000 after buying an additional 36,233 shares in the last quarter. Parallel Advisors LLC lifted its stake in shares of Danaher by 7.9% during the 3rd quarter. Parallel Advisors LLC now owns 7,682 shares of the conglomerate’s stock valued at $835,000 after buying an additional 562 shares in the last quarter. Wedge Capital Management L L P NC lifted its stake in shares of Danaher by 8.7% during the 3rd quarter. Wedge Capital Management L L P NC now owns 323,136 shares of the conglomerate’s stock valued at $35,112,000 after buying an additional 25,912 shares in the last quarter. Finally, Valeo Financial Advisors LLC lifted its stake in shares of Danaher by 9.4% during the 3rd quarter. Valeo Financial Advisors LLC now owns 6,673 shares of the conglomerate’s stock valued at $663,000 after buying an additional 571 shares in the last quarter. Institutional investors and hedge funds own 76.80% of the company’s stock.

In other news, EVP William K. Daniel sold 29,784 shares of the business’s stock in a transaction dated Thursday, October 25th. The shares were sold at an average price of $98.04, for a total value of $2,920,023.36. Following the sale, the executive vice president now directly owns 141,892 shares in the company, valued at approximately $13,911,091.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP William K. Daniel sold 103,086 shares of the business’s stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $100.63, for a total transaction of $10,373,544.18. Following the completion of the sale, the executive vice president now owns 167,080 shares in the company, valued at $16,813,260.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 143,448 shares of company stock worth $14,306,623. Insiders own 11.90% of the company’s stock.

Shares of NYSE DHR opened at $101.25 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.08 and a current ratio of 1.53. The firm has a market capitalization of $70.97 billion, a price-to-earnings ratio of 25.12, a P/E/G ratio of 1.95 and a beta of 1.04. Danaher Co. has a 52-week low of $91.65 and a 52-week high of $110.13.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The company had revenue of $4.85 billion for the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.59%. Danaher’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.00 EPS. On average, equities analysts forecast that Danaher Co. will post 4.51 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, October 26th. Shareholders of record on Friday, September 28th were issued a $0.16 dividend. The ex-dividend date was Thursday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 0.63%. Danaher’s dividend payout ratio is currently 15.88%.

DHR has been the topic of a number of analyst reports. ValuEngine upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Thursday, July 12th. Morgan Stanley lifted their target price on shares of Danaher from $113.00 to $120.00 and gave the company an “overweight” rating in a research note on Friday, July 13th. Zacks Investment Research cut shares of Danaher from a “hold” rating to a “sell” rating in a research note on Monday, July 16th. Bank of America set a $113.00 target price on shares of Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Finally, Royal Bank of Canada lifted their target price on shares of Danaher to $107.00 and gave the company a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $112.14.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: Treasury Bonds

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply